Approved Study Database

Ref. No. Scientific Title Principal investigator
2012.279 A randomized parallel group single blinded study of effects of Dayan (Wild Goose) Qigong on type 2 diabetes patients with low cardiovascular risk. Dr. Tsang Chiu-Chi
2012.278 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate Cardiovascular Outcomes of TAK-875, 50 mg in Addition to Standard of Care in Subjects with Type 2 Diabetes and with Cardiovascular Disease or Multiple Risk Factors for Cardiovascular Events Dr. TSANG Chiu Chi
2012.277 A Phase 3, Randomized, Double-Blind, Controlled Study Evaluating the Efficacy and Safety of Peginterferon Lambda-1a, with and without Daclatasvir, Compared to Peginterferon Alfa-2a, Each in Combination with Ribavirin, in the Treatment of Na_ve Genotype 2 and 3 Chronic Hepatitis C Subjects Dr Hui Aric Josun
2012.276 A Double-blind, Randomized, Multicenter Study to Evaluate Safety and Efficacy of AMG 145, Compared With Ezetimibe, in Hypercholesterolemic Subjects Unable to Tolerate an Effective Dose of a HMG-CoA Reductase Inhibitor Professor Tomlinson Brian
2012.274 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate Cardiovascular Outcomes of TAK-875, 50 mg in Addition to Standard of Care in Subjects with Type 2 Diabetes and with Cardiovascular Disease or Multiple Risk Factors for Cardiovascular Events Dr. CHOW Francis Chun-Chung
2012.273 A Double-blind, Randomized, Placebo and Ezetimibe Controlled, Multicenter Study to Evaluate Safety, Tolerability and Efficacy of AMG 145 on LDL-C in Combination With Statin Therapy in Subjects With Primary Hypercholesterolemia and Mixed Dyslipidemia Dr Ozaki Risa
2012.271 Evaluate the efficacy of neutropenia care education program for breast cancer patients receiving doxorubicin and cyclophosphamide: Application of empowerment process model Miss Mak Wai Chi
2012.269 A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate Safety, Tolerability and Efficacy of AMG 145 on LDL-C in Subjects with Heterozygous Familial Hypercholesterolemia Professor Tomlinson Brian
2012.266 The Impact of Neuronavigated Repetitive Transcranial Magnetic Stimulation on Tinnitus Distress and Health-related Quality of Life Prof Kam Chi Shan
2012.257 A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid in the Treatment of Bone Disease in Subjects with Newly Diagnosed Multiple Myeloma Dr. WONG Raymond Siu Ming
2012.251 Prospective Randomized Comparison of the Block Dynamics after a Traditional Landmark Based and Ultrasound Guided Thoracic Paravertebral Block Prof. KARMAKAR Manoj Kumar
2012.245 A randomized-controlled study of endoscopic submucosal dissection (ESD) for early gastric cancer with and without EndoLifter Dr. Teoh Yuen Bun, Anthony
2012.242 A randomized controlled single blind crossover trial comparing arterial oxygen saturation and carbon dioxide tension using a new automated ventilation mode, Intellivent Prof Gomersall Charles
2012.238 A randomized, controlled clinical trial: The benefits of a group transdiagnostic cognitive-behavioral therapy (TCBT) with mood-related disorders in Chinese community Professor Leung Patrick
2012.236 Effectiveness of Acupuncture for the Treatment of Post-Stroke Dysphagia: A Pragmatic Trial Comparing Real Acupuncture Treatment with Waiting List Prof. LIN Zhi Xiu
2012.232 A Multinational, Randomized, Double-Blind Study of Aflibercept Versus Placebo with Irinotecan/5-FU Combination (FOLFIRI) in Patients with Metastatic Colorectal Cancer (MCRC) after failure of an Oxaliplatinb Based Regimen Dr MA Brigette Buig Yue
2012.230 A Multicenter, International, Randomized, Double-blind, Alendronate-controlled Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis Prof. LEUNG Ping Chung
2012.225 A Randomized, Phase III, Multicenter, Double Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of MetMAb in Combination With Tarceva (Erlotinib) in Patients with Met Diagnostic-Positive Non-Small Cell Lung Cancer (NSCLC) who have Received Standard Chemotherapy for Advanced or Metastatic Disease Prof. Mok Shu-Kam
2012.224 Randomised Placebo Controlled Trial of Inhaled Corticosteroids for Treatment of Acute Cough in Children Prof. LI Albert Martin
2012.218 LUX-Lung 7: A randomised, open label Phase IIb Trial of afatinib versus gefitinib as first-line treatment of patients with EGFR mutation positive advanced adenocarcinoma of the lung Prof. MOK Tony Shu Kam
2012.217 An exploratory study on the effects of Integrated Attention training for healthy older Chinese adults with subjective cognitive complaints but no clinical dementia Dr. Cheng Pak Wing
2012.213 The use of acupuncture for generalized anxiety disorder: a randomized controlled clinical trial Prof. Wong Samuel Yeung Shan
2012.208 Enhanced Control of Hypertension and Thrombolysis Stroke Study Prof. LEUNG Thomas Wai Hong
2012.204 Acupuncture for pelvic/low back pain during pregnancy Prof. WANG Chi Chiu
2012.200 A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects with Systemic Lupus Erythematosus Prof. TAM Lai Shan
2012.199 A Multicentre Randomized Program to Compare the Effect of the Joint Asia Diabetes Evaluation (JADE, structured care) versus the DIAbetes MONitoring Database (DIAMOND, usual care) Programs in Type 2 Diabetic Patients in Asia Pacific Region Prof. CHAN Juliana
2012.198 An Investigation of the Effect of Long-Term Electrical Stimulation on Lower Esophageal Sphincter (LES) Pressure and Esophageal Acid Exposure in Patients with Gastroesophageal Reflux Disease (GERD) Prof Wu Che Yuen Justin
2012.197 Cognitive Function after Nitrous Oxide Anesthesia: A randomized Controlled Trial Dr Chan Matthew Tak Vai
2012.193 Laparoscopic adrenalectomy versus radiofrequency ablation for aldosterone-producing adenoma: a prospective randomized controlled trial Prof. NG Enders K.W.
2012.192 A pilot case-control study of second or third line treatment with cetuximab-containing chemotherapy in patients with metastatic colorectal cancer who were previously treated with cetuximab-based chemotherapy Prof. MA Brigette
2012.191 A randomized, double-blind, placebo-controlled phase III study of regorafenib plus best supportive care (BSC) versus placebo plus BSC in Asian subjects with metastatic colorectal cancer (CRC) who have progressed after standard therapy (CONCUR) Prof. Ma Brigette Buig - Yue
2012.185 The effect of a psychoeducational intervention for the stroke family caregivers on their problem-solving abilities, physical health, psychosocial wellbeing and family functioning, and the health services utilization of stroke survivors: A randomized controlled trial Miss Cheng Ho Yu
2012.179 Bleach bath and S. aureus in childhood onset moderate-to-severe eczema Professor Hon Kam-Lun Ellis
2012.175 The use of B vitamins to prevent cognitive decline in older mild cognitive impairment patients with elevated plasma homoscsteine - A randomized placebo controlled trial Prof. KWOK Timothy
2012.166 Aneurysm Neck Reconstruction Device (ANRD) For Treatment of Bifurcation Aneurysms Professor_x000D_Professor Wong_x000D_Yu Kwok Chu _x000D_Chun Ho
2012.160 EUS-guided gallbladder drainage with the AXIOS stent in patients with acute cholecystitis unsuitable for surgery: a feasibility study. Dr. TEOH Anthony Yuen Bun
2012.153 A randomized controlled trial of endoscopic biliary radiofrequency ablation of malignant distal common bile duct strictures Dr. TEOH Anthony Yuen Bun
2012.151 A randomised, double-blind, placebo-controlled, parallel-group, multicentre study to determine the efficacy and safety of 2 doses of retigabine immediate release (900 mg/day and 600 mg/day) used as adjunctive therapy in adult Asian subjects with drug-resistant partial-onset seizures Dr Kwan Patrick Kwok Leung
2012.150 An Open-Label, Randomized, Phase 2 Study to Access the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Patients with Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Dr. Wong Siu Ming Raymond
2012.145 A PHASE III PROSPECTIVE, TWO-COHORT NON-RANDOMIZED, MULTI-CENTRE, MULTINATIONAL, OPEN LABEL STUDY TO ASSESS THE SAFETY OF ASSISTED- AND SELF-ADMINISTERED SUBCUTANEOUS TRASTUZUMAB AS THERAPY IN PATIENTS WITH OPERABLE HER2-POSITIVE EARLY BREAST CANCER [SafeHer Study] Prof. YEO Winnie
2012.140 Effect of an innovative herbal supplementation on oxidative stress and muscle micro-damage after exercise in healthy males: a double-blinded corssover-designed experimental study Prof. Wong Heung-Sang Stephen
2012.138 Development of an automatic physical activity measuring and reporting system for online exercise promotion: the Virtual Trainer 3rd Version. Professor Hui Stanley Sai-chuen
2012.137 A pilot study on robotic laparoendoscopic single site cholecystectomy Prof. NG Enders Kwok Wai
2012.136 Evaluation of Morbidities, Endpoints and Reaching targets in Diabetic patients managed by an All-encompassing program Led by a Diabetes specialist team (EMERALD) Prof CHAN Chung Ngor Juliana
2012.134 A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTI-CENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ONCE-DAILY ADMINISTRATION OF A PHOSPHODIESTERASE 5 INHIBITOR (PF-00489791) IN ADULTS WITH TYPE 2 DIABETES AND OVERT NEPHROPATHY Dr Ozaki Risa
2012.133 A Randomized, Open Label, Multi-National Study of Cabazitaxel At 25 mg/m_ Every 3 Weeks in Combination With Prednisone Compared To Mitoxantrone in Combination With Prednisone in Asian Patients with Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen Dr HO Wing-Ming
2012.132 A prospective, double blind, randomised trial comparing nebulised sodium heparin versus placebo in ventilator associated pneumonia prevention (IPHIVAP study) Dr WAI KA MING
2012.129 A phase I open-label dose escalation study with expansion to assess the safety and tolerability of INC280 in patients with c-MET dependent advanced solid tumors Prof. MA Brigette Buig Yue
2012.118 Intensification of pre-operative therapy with multi-agent chemotherapy and concurrent chemoradiotherapy prior to total mesorectal excision surgery in patients with high risk rectal cancer Prof. MA Brigette
2012.109 A Phase III, multicentre, international, randomised, parallel group, double blind cardiovascular safety study of BI 10773 (10 mg and 25 mg administered orally once daily) compared to usual care in type 2 diabetes mellitus patients with increased cardiovascular risk Dr. TSANG Chiu Chi

Page 221 of 254.